Celgene Corp (CELG) 115.28 $CELG Final Glance:

New Post Public Reply Private Reply Replies (0) Message Board

Mar 31, 2015 at 6:42 PM

Celgene Corp (CELG) 115.28 $CELG

Final Glance: Biotechnology companies
AP - 44 mins ago
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:
GILD: 98.13 (-2.56), AMGN: 159.85 (-4.45), CELG: 115.28 (-4.74)

Midday Glance: Biotechnology companies
AP - Tue Mar 31, 1:48PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.:
GILD: 98.13 (-2.56), AMGN: 159.85 (-4.45), CELG: 115.28 (-4.74)

Gilead Versus Celgene: Value Play Versus Reinvestment Opportunity
Intrepid Investor - at Seeking Alpha - Tue Mar 31, 1:36PM CDT

GILD: 98.13 (-2.56), CELG: 115.28 (-4.74)

Stocks Ease Off Day's Lows; Ambarella Bucks Weakness
at Investor's Business Daily - Tue Mar 31, 12:19PM CDT
Stocks were off their session lows, but still lower Tuesday afternoon following mixed economic data. The Nasdaq and the S&P 500 were each off 0.4%. They were down 0.6% at Tuesday's low. The Dow Jones industrial average lost 0.5%. Volume was tracking...
AMBA: 75.71 (+1.10), LRCX: 70.23 (-1.96), SNDK: 63.62 (-1.36), CELG: 115.28 (-4.74)

Cancer PD-1 inhibitor market only half as large as consensus says analyst
Seeking Alpha - at Seeking Alpha - Tue Mar 31, 11:37AM CDT

MDVN: 129.07 (-4.87), AZN: 68.43 (-1.51), MRK: 57.48 (-0.86), BMY: 64.50 (-1.26), SRNE: 11.56 (+0.20), CELG: 115.28 (-4.74), FPRX: 22.85 (-0.91)

Early Glance: Biotechnology companies
AP - Tue Mar 31, 9:29AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 10 a.m.:
GILD: 98.13 (-2.56), AMGN: 159.85 (-4.45), CELG: 115.28 (-4.74)

Celgene Corporation (Nasdaq: CELG) to Ring The Nasdaq Stock Market Closing Bell
GlobeNewswire - Tue Mar 31, 9:00AM CDT
What:
QQQ: 105.60 (-1.13), NDAQ: 50.94 (+0.24), CELG: 115.28 (-4.74), CELGZ: 2.97 (+0.16)

'Fast Money' Recap: A Stock Rally With 'Window Dressing'
at The Street - Tue Mar 31, 4:00AM CDT
The trading panel discussed volatility, GoPro and biotech stocks.
TSLA: 188.77 (-1.80), GPRO: 43.41 (-0.17), SPY: 206.43 (-1.82), GILD: 98.13 (-2.56), C: 51.52 (-0.12), IBB: 343.43 (-7.89), AMGN: 159.85 (-4.45), IWM: 124.37 (-0.40), IYT: 156.62 (-0.84), INTC: 31.27 (-0.19), CELG: 115.28 (-4.74)

Stock Market News for March 30, 2015 - Market News
Zacks Equity Research - Zacks Investment Research - Mon Mar 30, 9:10AM CDT
Benchmarks ended the last trading session of the week on a positive note after Fed Chair Janet Yellen said there was a possibility of a gradual hike in interest rates sometime this year
BIIB: 422.24 (-9.38), VRTX: 117.97 (-3.28), HD: 113.61 (-1.02), RYL: 48.74 (-0.17), ALTR: 42.91 (+0.09), AMGN: 159.85 (-4.45), XOM: 85.00 (-0.63), INTC: 31.27 (-0.19), CELG: 115.28 (-4.74), LEN: 51.81 (+0.32), CVX: 104.98 (-1.92), TOL: 39.34 (+0.13), REGN: 451.48 (-8.30)

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Mar 27, 6:59PM CDT
Cramer will look for any inkling of growth when industrial stocks report earnings next week.
GD: 135.73 (-1.78), BIIB: 422.24 (-9.38), F: 16.14 (-0.02), LMT: 202.96 (-1.93), SHAK: 50.05 (+0.43), MON: 112.54 (-0.84), FRPT: 19.43 (-0.62), RTN: 109.25 (-1.74), NOC: 160.96 (-1.72), GMCR: 111.73 (-2.23), BWLD: 181.24 (-1.73), AIR: 30.70 (-0.76), JACK: 95.92 (-1.12), KMX: 69.01 (-0.21), SONC: 31.70 (-0.59), CMG: 650.54 (-4.82), REGN: 451.48 (-8.30), YUM: 78.72 (-0.69), MU: 27.13 (+0.45), SWKS: 98.29 (-1.84), NXPI: 100.36 (-2.07), PLKI: 59.82 (-0.92), FRGI: 61.00 (-1.03), CELG: 115.28 (-4.74), MS: 35.69 (-0.62), QRVO: 79.70 (-1.70), CBRL: 152.14 (-0.65), GILD: 98.13 (-2.56), NDLS: 17.44 (-0.10), GM: 37.50 (-0.18), MCD: 97.44 (-0.44), DOW: 47.98 (-0.70), AVGO: 126.98 (-3.57), LLL: 125.79 (-0.90)

A Buyback Or Biotech Bubble?
Leo Kolivakis - Seeking Alpha - Fri Mar 27, 1:37PM CDT
(click to enlarge) Steven Davidoff Solomon, professor of law at the University of California, Berkeley, wrote a comment for the New York Times reports, General Motors' Stock Buyback Follows a Worrying Trend : General Motors' announcement that...
BIIB: 422.24 (-9.38), GILD: 98.13 (-2.56), XBI: 225.50 (+1.13), IBB: 343.43 (-7.89), PKW: 49.31 (-0.38), CELG: 115.28 (-4.74)

Jim Cramer -- There's No Bubble in Biotech or Semiconductor Sectors
at The Street - Fri Mar 27, 10:23AM CDT
Some of Cramer's favorite companies are rising with their sectors Friday.
BIIB: 422.24 (-9.38), QRVO: 79.70 (-1.70), SWKS: 98.29 (-1.84), IBB: 343.43 (-7.89), SMH: 55.30 (-0.56), NXPI: 100.36 (-2.07), REGN: 451.48 (-8.30), AVGO: 126.98 (-3.57), CELG: 115.28 (-4.74)

Wait For The Big Biotechs To Stabilize - Cramer's Lightning Round (3/26/15)
SA Editor Mohit Manghnani - Seeking Alpha - Fri Mar 27, 5:00AM CDT
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Thursday, March 26. Bullish Calls: Halliburton (NYSE: HAL ): "Please do not sell it. We are finally getting to levels where I think that the worst is priced...
DVAX: 22.43 (-0.71), GPRO: 43.41 (-0.17), SWKS: 98.29 (-1.84), GRUB: 45.39 (-0.84), HAL: 43.88 (+0.06), HIMX: 6.33 (-0.11), MAR: 80.32 (-1.18), H: 59.22 (+0.21), CSCO: 27.52 (-0.13), KERX: 12.73 (-0.31), CELG: 115.28 (-4.74)

Agios' PK Deficiency Drug AG-348 Gets Orphan Drug Status - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 26, 5:50PM CDT
Agios Pharmaceuticals (AGIO) announced that its PK deficiency candidate, AG-348 has been granted orphan drug status by the FDA.
LCI: 67.71 (-0.15), CBM: 39.63 (+4.04), AGIO: 94.30 (-4.50), CELG: 115.28 (-4.74)

Stocks Turn Flat in Bumpy Session; Crude Settles Above $51
at The Street - Thu Mar 26, 1:53PM CDT
Stocks recover from heavy losses suffered earlier Thursday.
IBB: 343.43 (-7.89), MYL: 59.35 (-0.65), LULU: 64.02 (-0.81), SLB: 83.44 (-1.04), CELG: 115.28 (-4.74), GILD: 98.13 (-2.56), ALXN: 173.30 (-6.96), RHT: 75.75 (-0.94), TWC: 149.88 (+0.61), CMCSA: 56.47 (-0.14)

Celgene backs away from development of mAb for blood cancer
Seeking Alpha - at Seeking Alpha - Thu Mar 26, 12:04PM CDT

CELG: 115.28 (-4.74)

Biotech Stock Selloff: Is It Justified?
at Investor's Business Daily - Thu Mar 26, 11:12AM CDT
Biotech stocks continued to slide Thursday, prompting analysts to weigh in on the causes and prognosis for the sector. Piper Jaffray's Joshua Schimmer noted that the same thing happened about a year ago, sparked by the price debate over Gilead...
BIIB: 422.24 (-9.38), VRTX: 117.97 (-3.28), BMRN: 124.62 (-4.51), KITE: 57.68 (-2.30), GILD: 98.13 (-2.56), ALXN: 173.30 (-6.96), JUNO: 60.66 (-0.09), CELG: 115.28 (-4.74)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

OmniActive's Fenavari: A New Era in Women's Health

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...

Quark Baby's Milk Warmer Debut at Vancouver & Dubai

An Unconventional Pitch for Baby Gear Quark Baby is strutting its stuff not just in Vancouver but all the way in Dubai. Yeah, we're talking about a milk warmer hitting two major expos. What's the deal with an award-winning brand from Vancouver making so much noise? From October 17-18, they're home-court at The Baby Show Vancouver, and by October 22-24, they're in Dubai at...

Fluence Energy Faces Major Lawsuit Amid $3B Loss

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Think Tank Pushes for Bold Parkinson's Prevention Plan

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Omneky Outshines Competitors in AI Ad Scoring

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

CMC Declares Dividend Amid Complex Outlook

Dividend's Not Just a Regular Check October 13, 2026, marks yet another dividend declaration by CMC. This time, they're dishing out $0.20 per share—a steady payday for loyal shareholders. That's 248 times in a row they've done this song and dance. Odds are, folks holding NYSE:CMC shares are giving the nod of approval, but it ain't just about cash; it's about stability...

New American Funding Expands in Carolinas with Mullinix Move

The Gathering of Mortgage Titans You don't just waltz into the mortgage world with a $2 billion track record and expect folks not to notice. Will Mullinix, a name that's become synonymous in the Carolinas with mortgage mastery, has decided to bring his influential Mullinix Mortgage Group under the banner of New American Funding. Talk about a power play. This bold strategy...

VetsinTech's AI Training Boosts Military Careers

A New Spin on Engineering Careers Sometimes it feels like every corner I turn in this market maze, there’s something about AI. It’s not just chirping in the tech world anymore; it’s banging on the doors of sectors like engineering, aerospace, and manufacturing. And now, VetsinTech is tossing its hat into the AI ring with a fresh program aimed at blending military...

Coventry's Jacobs Joins European Life Settlement Execs

Neal Jacobs Steps Up in Life Settlements Coventry has added another feather to its cap with Neal Jacobs, their Senior Managing Director of Capital Markets, joining the Executive Committee of the European Life Settlement Association (ELSA). Elected at ELSA's Annual General Meeting on September 15, 2026, Jacobs brings a wealth of experience that promises to bolster the...